We are live on ! Find out more
LBPH

Longboard Pharmaceuticals, Inc. Common Stock
LBPH

Delisted

LBPH was delisted on the 29th of November, 2024.

Back to rankings

25 hedge funds and large institutions have $51.5M invested in Longboard Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

600% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 2

121% more capital invested

Capital invested by funds: $23.3M → $51.5M (+$28.1M)

39% more funds holding

Funds holding: 18 → 25 (+7)

Holders
25
Holders Change
+7
Holders Change %
+38.89%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
14
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.77M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$6.1M
3
PM
Prosight Management
Texas
+$4.4M
4
FCM
Farallon Capital Management
California
+$3.66M
5
IHAM
Integral Health Asset Management
New York
+$1.66M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$226K
2
UBS Group
UBS Group
Switzerland
-$2.16K
3
Bank of America
Bank of America
North Carolina
-$36
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$11.4M +$8.77M +1,795,488 +163%
CAM
2
Cormorant Asset Management
Massachusetts
$9.44M +$1.15M +234,858 +11%
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$5.76M -$226K -46,187 -3%
FCM
4
Farallon Capital Management
California
$5.29M +$3.66M +750,000 +93%
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$5.01M +$6.1M +1,250,000 New
Millennium Management
6
Millennium Management
New York
$4.12M +$293K +59,993 +6%
PM
7
Prosight Management
Texas
$3.61M +$4.4M +900,600 New
IHAM
8
Integral Health Asset Management
New York
$2.33M +$1.66M +339,000 +140%
Vanguard Group
9
Vanguard Group
Pennsylvania
$1.6M +$449K +91,896 +30%
UOC
10
UBS O'Connor
Illinois
$904K +$1.12M +230,000 New
WP
11
Woodline Partners
California
$459K +$559K +114,569 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$322K +$4.7K +962 +1%
CIBC Asset Management
13
CIBC Asset Management
Ontario, Canada
$225K +$274K +56,125 New
BCM
14
Bourgeon Capital Management
Connecticut
$200K +$226K +46,355 +1,324%
BCM
15
Bridgeway Capital Management
Texas
$197K +$122K +25,000 +100%
TD Asset Management
16
TD Asset Management
Ontario, Canada
$148K – – –
LCM
17
Laurion Capital Management
New York
$122K +$48.8K +10,000 +48%
BlackRock
18
BlackRock
New York
$116K +$46.4K +9,502 +49%
Manulife (Manufacturers Life Insurance)
19
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$111K +$138K +28,249 New
Northern Trust
20
Northern Trust
Illinois
$71.3K +$86.9K +17,790 New
TRCT
21
Tower Research Capital (TRC)
New York
$12K +$1.15K +236 +8%
Citigroup
22
Citigroup
New York
$10.9K +$13.5K +2,768 New
UBS Group
23
UBS Group
Switzerland
$2.12K -$2.16K -443 -46%
Morgan Stanley
24
Morgan Stanley
New York
$678 +$811 +166 +5,533%
Wells Fargo
25
Wells Fargo
California
$377 +$176 +36 +62%
1
2

LBPH Hedge Fund Activity: Q1 2023 in Review

25 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Longboard Pharmaceuticals, Inc. Common Stock (LBPH) for Q1 2023, worth a combined $51.5M — up 121% from $23.3M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new LBPH positions and 1 closed out — a net gain of 7 holders — while 14 added to existing stakes and 2 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $8.77M. The largest seller was T. Rowe Price Associates, cutting an estimated $226K.

  • 25 institutional investors held Longboard Pharmaceuticals, Inc. Common Stock (LBPH) as of Q1 2023, up from 18 in Q4 2022.
  • Funds reported $51.5M of Longboard Pharmaceuticals, Inc. Common Stock stock for Q1 2023, up 121% quarter-over-quarter.
  • 8 funds opened new Longboard Pharmaceuticals, Inc. Common Stock positions in Q1 2023 and 1 closed out, a net change of +7 holders.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock buyer in Q1 2023 was Fidelity Investments, an estimated $8.77M added.
  • The largest Longboard Pharmaceuticals, Inc. Common Stock seller in Q1 2023 was T. Rowe Price Associates, an estimated $226K sold.

Based on aggregated 13F filings for Q1 2023.